Blood Glucose Monitoring Devices Market Share

  • Report ID: 4606
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Blood Glucose Monitoring Devices Market Share

North American Market Forecast

The North America blood glucose monitoring devices market is projected to hold the largest market share by the end of 2037. The growth of the market can be attributed majorly to the rising cases of diabetes with the prevalence of obesity owing to an inactive lifestyle. For instance, it was estimated that around 32.2 million people in the United States, were suffering from diabetes in 2021. Further, the huge investment in research and development activities, along with the increasing adoption of technologically advanced devices, are some further factors that are anticipated to boost the market growth. In addition, the expanding per capita medical expenditure is also anticipated to drive the market growth further during the projected time frame.

APAC Market Statistics

Further, the Asia Pacific blood glucose monitoring devices market is also estimated to display lucrative revenue by the end of 2037. The growth of the market can be attributed to the large pool of diabetes patients who have been dealing with insulin-dependent diabetes, along with the escalating ratio of aged people in the region. In addition to this, rising awareness about diabetes preventive care, followed by improving healthcare facilities are some more factors that are anticipated to drive the growth of the market in the region throughout the forecast period.

 

Research Nester
Blood Glucose Monitoring Devices Market Size
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4606
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of blood glucose monitoring devices is estimated at USD 20.82 billion.

The blood glucose monitoring devices market size was valued at USD 19.31 billion in 2024 and is expected to cross USD 64.98 billion by the end of 2037, expanding at more than 9.7% CAGR during the forecast period i.e., between 2025-2037. Increasing perforation of continuous blood glucose monitoring (CGM) devices, rising ubiquity of diabetes, and growing investment in diabetic research activities will boost the market growth.

North America industry is poised to dominate largest revenue share by 2037, due to rising cases of diabetes with the prevalence of obesity owing to an inactive lifestyle in the region.

The major players in the market include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Ascensia Diabetes Care Holdings AG, Dexcom, Inc., NIPRO CORPORATION, Prodigy Diabetes Care, LLC, ACON Laboratories, Inc., Insulet Corporation, Ypsomed AG, Terumo Corporation.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample